The effect of curcumin on arterial stiffness

Phase 3

• Conditions: metabolic syndrome.

• Registration Number: IRCT20180619040151N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Willingness to participate in the study and the completion of informed consent form
Metabolic syndrome Patients

Exclusion Criteria

Curcumin sensitivity
Regular use of anti-diabetes drugs, antiplatelet drugs, antioxidant supplements, anti-inflammatory drugs, analgesics
Use of multivitamin or herbal supplements at least 3 months before the start of the study
Liver disease, autoimmune disease, biliary disease, obstructive disease, diabetes, kidney failure, malignancy, kidney stones, calcium oxalate stones
Pregnancy and breastfeeding
Drug abuse
Smoking hookah or cigarettes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulse wave velocity. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.;Central Augmentation Index. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.;Central Augmentation Index75. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.;Central augmentation pressure. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.;Brachial blood pressure. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.;Central blood pressure. Timepoint: At the beginning and the end of the study. Method of measurement: Sphygmocor xcel.